ENvue Medical, Inc. (FEED)
Oxford Ledge is still expanding full research coverage of FEED. A delayed quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
ENvue Medical operates medical device subsidiaries focused on enteral feeding navigation systems and biofilm-prevention therapies.
Source: 10-K (2025-12-31) · AI-generated analysis. Not investment advice. May contain errors.
SEC filings
- 8-K Delisting / transfer of listing; Financial statements and exhibits 2026-07-10
- 10-Q Quarterly financial report (unaudited) 2026-05-18
- 10-K Annual financial report with audited statements 2026-04-15
- 8-K Departure/election of directors or officers; Financial statements and exhibits 2026-02-06
- 8-K Entry into material agreement; 3.03; Amendments to articles or bylaws; Financial statements and exhibits 2026-01-30
Source: SEC EDGAR.
Annual results
5 years of annual figures for FEED, as filed with the SEC. Figures are as reported and are not restated or adjusted.
| Fiscal year | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| 2025 | $2.6M | -$18.2M | -$26.69 |
| 2024 | $2.6M | -$3.7M | -$137.30 |
| 2023 | $2.3M | -$3.7M | -$23.32 |
| 2022 | $752,000 | -$5.4M | -$3.84 |
| 2021 | $1.7M | -$14.3M | — |
Source: SEC EDGAR (XBRL company facts). Full statements and ratios in the terminal.
Insider activity
5 recent insider (SEC Form 4) filings on record for FEED. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open FEED in the Oxford Ledge terminal — delayed quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.